Engdahl E, et al. Serological response against HHV-6A is associated with increased risk for multiple sclerosis. Abstract 222. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
Risicofactoren voor ‘late-onset’ epilepsie
aug 2018 | Diabetes, Epilepsie
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen